Aytu BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AYTU?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	604,678	5.63%
Institutions	1,942,092	18.1%
Hedge Funds	2,498,675	23.3%
General Public	5,687,763	53%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.6%.

Top Shareholders

Top 25 shareholders own 46.07% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.1%	Nantahala Capital Management, LLC	1,086,812	US$2.3m	0%	0.14%
7.38%	Stonepine Capital Management LLC	792,289	US$1.7m	-2.63%	0.86%
5.77%	AWM Investment Company Inc	619,574	US$1.3m	0%	0.1%
4.63%	Lytton-Kambara Foundation	497,218	US$1.1m	0%	3.82%
3.29%	Diadema Partners LP	353,077	US$759.1k	15.5%	0.35%
2.43%	Vanguard Capital Management, LLC	261,146	US$561.5k	0%	no data
1.93%	Joshua Disbrow	207,203	US$445.5k	0%	no data
1.64%	Laurence Lytton	175,823	US$378.0k	0%	no data
1.35%	Crown Advisors Management, Inc.	145,000	US$311.8k	0%	0.17%
1.14%	Two Sigma Investments, LP	121,973	US$262.2k	13.9%	no data
0.87%	Renaissance Technologies LLC	93,723	US$201.5k	4.57%	no data
0.87%	Persistent Asset Partners Limited	92,897	US$199.7k	17%	0.06%
0.86%	Geode Capital Management, LLC	92,636	US$199.2k	25%	no data
0.57%	Jarrett Disbrow	61,568	US$132.4k	0%	no data
0.46%	Ryan Selhorn	49,743	US$106.9k	0%	no data
0.44%	Vanguard Fiduciary Trust Company	47,048	US$101.2k	0%	no data
0.41%	Dimensional Fund Advisors LP	43,585	US$93.7k	23.3%	no data
0.34%	Citadel Advisors LLC	36,841	US$79.2k	137%	no data
0.34%	Greg Pyszczymuka	36,102	US$77.6k	0%	no data
0.23%	Bellevue Asset Management, LLC	25,013	US$53.8k	0%	0.02%
0.21%	BlackRock, Inc.	22,793	US$49.0k	0%	no data
0.2%	XTX Markets Limited	21,582	US$46.4k	-16.5%	no data
0.2%	Carl Dockery	21,152	US$45.5k	0%	no data
0.19%	Perritt Capital Management, Inc.	20,000	US$43.0k	0%	0.06%
0.19%	North Star Investment Management Corporation	20,000	US$43.0k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/14 18:44
End of Day Share Price	2026/06/12 00:00
Earnings	2026/03/31
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aytu BioPharma, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Edward Woo	Ascendiant Capital Markets LLC
Jeffrey Cohen	Ladenburg Thalmann & Company
Thomas Flaten	Lake Street Capital Markets, LLC